Marker Therapeutics Inc’s filing revealed that its Director ELMS STEVE acquired Company’s shares for reported $35472.0 on Dec 23 ’24. In the deal valued at $3.20 per share,11,085 shares were bought. As a result of this transaction, ELMS STEVE now holds 325,370 shares worth roughly $ 0.56 million.
Then, New Enterprise Associates 16, bought 554,250 shares, generating $1,773,600 in total proceeds. Upon buying the shares at $3.20, the 10% Owner now owns 1,625,678 shares.
Piper Sandler initiated its Marker Therapeutics Inc [MRKR] rating to an Overweight in a research note published on March 25, 2021; the price target was $6. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Piper Sandler also remained covering MRKR and has decreased its forecast on May 12, 2020 with a “Neutral” recommendation from previously “an Overweight” rating. ROTH Capital started covering the stock on May 30, 2019. It rated MRKR as “a Buy”.
Price Performance Review of MRKR
On Friday, Marker Therapeutics Inc [NASDAQ:MRKR] saw its stock jump 1.18% to $1.72. Over the last five days, the stock has lost -2.82%. Marker Therapeutics Inc shares have fallen nearly -44.69% since the year began. Nevertheless, the stocks have fallen -58.80% over the past one year. While a 52-week high of $5.99 was reached on 01/03/25, a 52-week low of $1.48 was recorded on 02/12/25. SMA at 50 days reached $2.8497, while 200 days put it at $3.6073.
Levels Of Support And Resistance For MRKR Stock
The 24-hour chart illustrates a support level at 1.6567, which if violated will result in even more drops to 1.5933. On the upside, there is a resistance level at 1.7867. A further resistance level may holdings at 1.8533. The Relative Strength Index (RSI) on the 14-day chart is 36.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1489, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.09%. Stochastics %K at 26.47% indicates the stock is a holding.
How much short interest is there in Marker Therapeutics Inc?
A steep rise in short interest was recorded in Marker Therapeutics Inc stocks on 2025-01-31, growing by 0.12 million shares to a total of 0.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 0.11 million shares. There was a rise of 52.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 01, 2019 when Janney began covering the stock and recommended ‘”a Buy”‘ rating.
